Skip to main content

Table 2 Changes in calorie, percent from macronutrients, and dietary fiber throughout the study

From: Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial

Variable

Probiotic group (n = 22)

Placebo group (n = 22)

Mean difference

P-value

Energy (Kcal/d)

 Baseline

2214.14 (428.6)

2060.7 (454.38)

153.4 (− 116.1 to 422.8)

0.257**

 End

1829.34 (174.6)

1776.1 (184.3)

53.27 (− 32.1 to 138.68)

0.225***

MD (95% CI), P*

−384.71 (− 567.9 to −201.6), < 0.001

− 284.40 (− 447.40 to − 121.9), < 0.001

  

Carbohydrates (%)

 Baseline

53.33 (13.43)

54.1 (11.51)

0.80 (− 7.25, 5.78)

0.987**

 End

54.72 (10.22)

53.88 (11.34)

−0.92 (−7.31, 7.36)

0.807***

MD (95% CI), P*

1.39 (−7.12, 7.66), 0.667

−0.25 (−6.34, 5.12), 0.672

  

Protein (%)

 Baseline

13.55 (3.9)

13.99 (3.76)

0.44 (−2.21, 2.21)

0.087**

 End

15.08 (3.68)

15.7 (2.76)

0.62 (−2.3, 1.14)

0.379***

MD (95% CI), P*

1.53 (−3.44, 2.21), 0.172

1.71 (−2.21, 0.72), 0.634

  

Fat (%)

 Baseline

34.12 (9.87)

32.1 (7.72)

−2.01 (−5.03, 8.59)

0.751**

 End

30.20 (10.62)

31.12 (10.85)

1.01 (−6.23, 5.20)

0.756***

MD (95% CI), P*

−4.08 (−7.21, 3.33), 0.662

−2.00 (− 4.12, 5.31), 0.656

  

Dietary fiber (g)

 Baseline

16.40 (4.25)

15.72 (3.17)

−0.68 (−1.2, 3.12)

0.559**

 End

19.77 (8.05)

17.72 (6.51)

−2.01 (− 2.12, 6.35)

0.342***

MD (95% CI), P*

3.37 (−0.06, 0.34), 0.090

2.00 (− 0.06, 0.41), 0.147

  
  1. Mean (SD) and Mean difference (95% CI) are presented for data
  2. * P based on Paired samples t-test
  3. ** P based on Independent samples t-test
  4. *** P based on ANCOVA adjusted for baseline values, PAL and weight